{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:46:53Z","timestamp":1791323213709,"version":"4.3.1"},"reference-count":21,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:italic>Mycobacterium ulcerans<\/jats:italic>\n            disease, or Buruli ulcer (BU), causes significant morbidity in West Africa. Clinically, the disease presents in the skin as either nonulcerative or ulcerative forms and often invades bones either subjacent to the skin lesion (contiguous osteomyelitis) or remote from the skin lesion (metastatic osteomyelitis). Osteomyelitis represents a severe form of the disease that often requires numerous surgical interventions, even amputations. Surgery is accepted as the present definitive treatment for BU. In the absence of an effective drug treatment, the need for the development of preventive and control strategies becomes paramount. No specific vaccine, however, is presently available for BU. Of 372 consecutive patients in Benin presenting with BU (confirmed by microbiological and histopathological analyses) whose\n            <jats:italic>Mycobacterium bovis<\/jats:italic>\n            BCG scar statuses were known, 196 children (&lt;15 years old) and 108 adults had neonatal BCG vaccination scars. Of 196 children with BCG scars, 17 (8.7%) had osteomyelitis, while 7 of 28 children without BCG scars (25.0%) had osteomyelitis. Of 108 adults with BCG scars, 17 (15.7%) had osteomyelitis, while 14 of 40 adults without BCG scars (35.0%) had osteomyelitis. Our results show that effective BCG vaccination at birth provides significant protection against the development of\n            <jats:italic>M. ulcerans<\/jats:italic>\n            osteomyelitis in children and adults. Therefore, health authorities should give attention to the enhancement of neonatal BCG vaccination coverage in all countries of Africa where BU is endemic. Protection against severe forms of BU and childhood tuberculosis would likewise be improved by this intervention.\n          <\/jats:p>","DOI":"10.1128\/iai.72.1.62-65.2004","type":"journal-article","created":{"date-parts":[[2003,12,20]],"date-time":"2003-12-20T02:48:22Z","timestamp":1071888502000},"page":"62-65","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":103,"title":["<i>Mycobacterium bovis<\/i>\n            BCG Vaccination as Prophylaxis against\n            <i>Mycobacterium ulcerans<\/i>\n            Osteomyelitis in Buruli Ulcer Disease"],"prefix":"10.1128","volume":"72","author":[{"given":"F.","family":"Portaels","sequence":"first","affiliation":[{"name":"Mycobacteriology Unit, Department of Microbiology, Institute of Tropical Medicine, B-2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Aguiar","sequence":"additional","affiliation":[{"name":"Centre Sanitaire et Nutritionnel Gbemoten, Zagnanado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Debacker","sequence":"additional","affiliation":[{"name":"Mycobacteriology Unit, Department of Microbiology, Institute of Tropical Medicine, B-2000 Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gue\u0301de\u0301non","sequence":"additional","affiliation":[{"name":"PNLUB, Cotonou, Benin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Steunou","sequence":"additional","affiliation":[{"name":"Centre Sanitaire et Nutritionnel Gbemoten, Zagnanado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zinsou","sequence":"additional","affiliation":[{"name":"Centre Sanitaire et Nutritionnel Gbemoten, Zagnanado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. M.","family":"Meyers","sequence":"additional","affiliation":[{"name":"Armed Forces Institute of Pathology, Washington, D.C. 20306"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"325","volume":"3","year":"1997","unstructured":"Aguiar, J., M. C. Domingo, A. Gu\u00e9d\u00e9non, W. M. Meyers, C. Steunou, and F. Portaels. 1997. L'ulc\u00e8re de Buruli, une maladie mycobact\u00e9rienne importante et en recrudescence au B\u00e9nin. Bull. Seances Acad. R. Sci. Outre-Mer3:325-356.","journal-title":"Bull. Seances Acad. R. Sci. Outre-Mer"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(93)90272-R"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.283.5403.854"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.3.1704-1707.2001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.4.1613-1621.2003"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"e_1_3_2_8_2","first-page":"262","volume":"60","year":"2000","unstructured":"Lagarrigue, V., F. Portaels, W. M. Meyers, and J. Aguiar. 2000. L'ulc\u00e8re de Buruli: attention aux atteintes osseuses! A propos de 33 cas observ\u00e9s au B\u00e9nin. Med. Trop.60:262-266.","journal-title":"Med. Trop."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.68.9.4623-4628.2002"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1995.52.219"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Meyers W. M. 1995. Mycobacterial infections of the skin p. 291-377. In W. Doerr and G. Seifert (ed.) Tropical pathology 2nd ed. vol. 8. Springer-Verlag Berlin Germany.","DOI":"10.1007\/978-3-642-57863-2_9"},{"key":"e_1_3_2_12_2","first-page":"1067","volume":"5","year":"2001","unstructured":"Pereira, S. M., I. Dourado, M. L. Barreto, S. S. Cunha, M. Y. Ichiara, M. A. Hijjar, J. C. Goes, and L. C. Rodrigues. 2001. Sensitivity and specificity of BCG scar reading in Brazil. Int. J. Tuberc. Lung Dis.5:1067-1070.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Portaels F. 1995. Epidemiology of mycobacterial diseases p. 207-222. In M. S. Schuster (ed.) Clinics in dermatology vol. 13. Elsevier Science Inc. New York N.Y.","DOI":"10.1016\/0738-081X(95)00004-Y"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.20506\/rst.20.1.1270"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05177-0"},{"key":"e_1_3_2_16_2","first-page":"1389","volume":"9","year":"2002","unstructured":"Portaels, F., J. Aguiar, M. Debacker, C. Steunou, C. Zinsou, A. Gu\u00e9d\u00e9non, and W. M. Meyers. 2002. Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin. Diagn. Lab. Immunol.9:1389-1391.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_17_2","unstructured":"Portaels F. C. Zinsou J. Aguiar M. Debacker E. de Biurrun A. Gu\u00e9d\u00e9non R. Josse V. Lagarrigue M. T. Silva C. Steunou and W. M. Meyers. Les atteintes osseuses dans l'ulc\u00e8re de Buruli: \u00e0 propos de 73 cas. Bull. S\u00e9ances Acad. R. Sci. Outre-Mer in press."},{"key":"e_1_3_2_18_2","unstructured":"Portaels F. P. Johnson and W. M. Meyers (ed.). 2001. Buruli ulcer. Diagnosis of Mycobacterium ulcerans disease. A manual for health care providers. WHO\/CDS\/GBUI\/2001.4:42p. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(76)90128-0"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5403-5411.2001"},{"key":"e_1_3_2_21_2","first-page":"111","year":"1969","unstructured":"Uganda Buruli Group. 1969. BCG vaccination against Mycobacterium ulcerans infection (Buruli ulcer). Lanceti:111-115.","journal-title":"Lancet"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12849-8"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.1.62-65.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.72.1.62-65.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:50:08Z","timestamp":1646455808000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.72.1.62-65.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1128\/IAI.72.1.62-65.2004"],"URL":"https:\/\/doi.org\/10.1128\/iai.72.1.62-65.2004","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"2003-06-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-09-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}